Phyllodes tumor of the breast: a clinic-pathologic study of 77 cases in a Hispanic cohort
Article Sidebar
Main Article Content
Introduction:
Breast Phyllodes tumors are rare breast tumors present in less than 1% of new cases of breast cancer, usually occurring among middle-aged women (40-50 yrs).
Objective:
This study shows diagnostic experience, surgical management and follows up of patients with this disease during a period of ten years in a oncology referral center.
Methods:
Retrospectively, breast cancer registries at the institution were reviewed, identifying 77 patients with Phyllodes tumors between 2002 and 2012, who had been operated on at the Instituto de Cancerología - Clínica Las Américas, in Medellín (Colombia). Clinical and histopathological data belonging to these cases was captured and analyzed and descriptive statistics were used.
Results:
The follow up median was 22.5 months (IQR: 10.5-60.0), average age was 47.2 yrs (SD: 12.4), mean tumor size was 3.6 cm (SD: 4.6), 88.3% of the patients (68 cases) presented negative margins and none of them received adjuvant chemotherapy. Of the patients with Phyllodes tumors; 33.8% had benign, 31.2% had borderline and 35.0% had malignant tumor. Disease-free survival was 85.8% and overall survival was 94.5%.
Discussion:
Reported data in this article is in accordance with what has been reported in worldwide literature. In our cohort even the high mean size of the tumors, the risk of local relapse and metastatic disease is low than previously reported in literature. Trials with longer follow up and molecular trials in Phyllodes tumors are necessary to understand the behavior of these tumors in Hispanics population.
- Breast
- fibroadenoma
- fibroepithelial tumor
- pathology
- phyllodes tumor.
Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer 2006;107(9):2127–33. DOI: https://doi.org/10.1002/cncr.22228
Tavassoli F, Pathology and genetics: tumours of the breast and female genital tract, No. 4. IARC; 2003. International Classification. 2003.
Salvadori B, Cusumano F, Del Bo R, Delledonne V, Grassi M, Rovini D, et al. Surgical treatment of phyllodes tumors of the breast. Cancer 1989;63(12):2532–6. DOI: https://doi.org/10.1002/1097-0142(19890615)63:12<2532::AID-CNCR2820631229>3.0.CO;2-Q
Reinfuss M, Mituś J, Duda K, Stelmach A, Ryś J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer 1996;77(5):910–6. DOI: https://doi.org/10.1002/(SICI)1097-0142(19960301)77:5<910::AID-CNCR16>3.0.CO;2-6
Ibáñez RG, Marambio G A, Jans B J, Gamboa G J, Adonis P P, Trewhela N R, et al. Tumor filoides de la mama. Revista Chilena de Cirugía 2010;62(2):119–24.
Barreto AU. Tumor filodes: diagnóstico y tratamiento Chile. Rev Chil Obstet Ginecol 1995;60(1):17–22.
Rodriguez J;Gomez A. Tumor filodes de la mama: revisión de 55 casos en el Hospital Oncológico Padre Machado. Rev Venez Oncol 2003;15(1):28–37.
Henriques A, Fernando AM, Mauro A, Zerbini S, Walder Y, De JBB, et al Tumor filodes: casuística da Unidade de Mastologia do H.B.D.F. Rev Bras Mastologia 1998;8(1):13–20.
Spitaleri G, Toesca A, Botteri E, Bottiglieri L, Rotmens Z. Breast phyllodes tumor: A review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol 2013 Jul 17. 1-10
Barrio A, Clark B, Goldberg J, Hoque L. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Annals of surgical 2007;14(10):2961–70. DOI: https://doi.org/10.1245/s10434-007-9439-z
Belkacémi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magné N, Malard Y, et al. Phyllodes tumor of the breast. International journal of radiation oncology, biology, physics 2008;70(2):492–500. DOI: https://doi.org/10.1016/j.ijrobp.2007.06.059
Jacklin RK, Ridgway PF, Ziprin P, Healy V, Hadjiminas D, Darzi A. Optimising preoperative diagnosis in phyllodes tumour of the breast. Journal of clinical pathology 2006;59(5):454–9. DOI: https://doi.org/10.1136/jcp.2005.025866
Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer 1993;71(10):3020–4. DOI: https://doi.org/10.1002/1097-0142(19930515)71:10<3020::AID-CNCR2820711022>3.0.CO;2-G
Lee AHS. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast. Histopathology 2008;52(1):45–57. DOI: https://doi.org/10.1111/j.1365-2559.2007.02893.x
Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Laé M, et al. Management of phyllodes breast tumors. The breast journal 2011;17(2):129–37. DOI: https://doi.org/10.1111/j.1524-4741.2010.01045.x
Morales-Vásquez F, Gonzalez-Angulo AM, Broglio K, Lopez-Basave HN, Gallardo D, Hortobagyi GN, et al. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast. The breast journal 2007;13(6):551–6. DOI: https://doi.org/10.1111/j.1524-4741.2007.00510.x
Hawkins RE, Schofield JB, Wiltshaw E, Fisher C, McKinna A. Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes. Cancer 1992;69(9):2271–5. DOI: https://doi.org/10.1002/1097-0142(19920501)69:9<2271::AID-CNCR2820690911>3.0.CO;2-7
Esposito NN, Mohan D, Brufsky A, Lin Y. Phyllodes Tumor. Archives of Pathology 2006;130:1516–21. DOI: https://doi.org/10.5858/2006-130-1516-PTACAI
Ibáñez R G, Marambio G A, Jans B J, Gamboa G J, Adonis P P, Trewhela N R, et al. Tumor filoides de la mama. Revista chilena de cirugía 2010;62(2):119–24. DOI: https://doi.org/10.4067/S0718-40262010000200005
Barth RJ, Wells W, Mitchell SE, Cole BF. A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Annals of surgical oncology 2009;16(8):2288–94. DOI: https://doi.org/10.1245/s10434-009-0489-2
Khosravi-Shahi P. Management of non-metastatic phyllodes tumors of the breast: review of the literature. Surgical oncology 2011;20(4):e143–8. DOI: https://doi.org/10.1016/j.suronc.2011.04.007
Downloads
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use